XRAY has been the topic of several other reports. Zacks Investment Research downgraded DENTSPLY SIRONA from a buy rating to a hold rating and set a $62.00 target price on the stock. in a report on Monday, May 27th. HC Wainwright reaffirmed a neutral rating and set a $57.00 target price (up from $55.00) on shares of DENTSPLY SIRONA in a report on Tuesday, July 9th. Evercore ISI began coverage on DENTSPLY SIRONA in a report on Friday, July 26th. They set an in-line rating on the stock. BidaskClub downgraded DENTSPLY SIRONA from a buy rating to a hold rating in a report on Tuesday, July 16th. Finally, Wolfe Research began coverage on DENTSPLY SIRONA in a report on Thursday, May 30th. They set a peer perform rating on the stock. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. DENTSPLY SIRONA has an average rating of Hold and a consensus target price of $53.77.
Shares of XRAY opened at $52.79 on Thursday. The firm has a market cap of $12.49 billion, a P/E ratio of 26.26, a PEG ratio of 1.98 and a beta of 0.98. DENTSPLY SIRONA has a 12 month low of $33.93 and a 12 month high of $59.40. The stock’s 50-day moving average is $57.00. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Stockholders of record on Friday, June 28th were given a $0.0875 dividend. The ex-dividend date was Thursday, June 27th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.35 annualized dividend and a dividend yield of 0.66%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 17.41%.
In other news, Director Betsy D. Holden bought 2,720 shares of the firm’s stock in a transaction that occurred on Thursday, June 6th. The stock was acquired at an average cost of $55.31 per share, with a total value of $150,443.20. Following the transaction, the director now directly owns 9,224 shares of the company’s stock, valued at approximately $510,179.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Daniel P. Key bought 3,697 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was purchased at an average cost of $54.68 per share, with a total value of $202,151.96. Following the completion of the transaction, the senior vice president now directly owns 9,024 shares in the company, valued at $493,432.32. The disclosure for this purchase can be found here. Over the last three months, insiders bought 26,417 shares of company stock valued at $1,425,395 and sold 129,762 shares valued at $7,142,203. Company insiders own 0.62% of the company’s stock.
A number of institutional investors have recently modified their holdings of XRAY. Pinnacle Bank bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at about $26,000. Hanseatic Management Services Inc. bought a new stake in DENTSPLY SIRONA in the 1st quarter valued at about $30,000. Cornerstone Advisors Inc. increased its position in DENTSPLY SIRONA by 62.0% in the 2nd quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock valued at $53,000 after buying an additional 346 shares in the last quarter. Arcadia Investment Management Corp MI bought a new stake in DENTSPLY SIRONA in the 2nd quarter valued at about $58,000. Finally, Private Capital Group LLC increased its position in DENTSPLY SIRONA by 74.7% in the 1st quarter. Private Capital Group LLC now owns 1,223 shares of the medical instruments supplier’s stock valued at $61,000 after buying an additional 523 shares in the last quarter. 91.93% of the stock is owned by institutional investors and hedge funds.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: Analyst Ratings Trading
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.